# Source:Dr. John Campbell, URL:https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg, language:en-UK

## Cases rise, new variant in US
 - [https://www.youtube.com/watch?v=h-sQuJanJSs](https://www.youtube.com/watch?v=h-sQuJanJSs)
 - RSS feed: https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg
 - date published: 2020-12-31 00:00:00+00:00

UK. Cases, + 50,023 = 2,432,888
https://www.bbc.co.uk/news/explainers-52530518
https://coronavirus.data.gov.uk/details/cases

Hospitalised, + 2,430 = 23,771 (ventilated, 1,847)

Previous peak, 12 April = 21,683

Injections versus infections

Vaccinated, 616,933

Deaths, + 981 = 72,548

Deaths, + 3,270 = 82,624

COVID symptom tracker data

https://covid.joinzoe.com

Cases, + 55,266 (plus 20%)

Verbier

About a dozen British tourists out of about 420 left in resort

Swiss health minister, Alain Berset

We are aware of that. It’s obviously a problem. There was an order to quarantine that has not been respected

About 3,500, from UK to Switzerland for Christmas

VOC Updates

Report 42 - Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: insights from linking epidemiological and genetic data

https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-42-sars-cov-2-variant/

Imperial College with MRC for Global Infectious Diseases Analysis

Available data indicate a shift in the age composition of reported cases, with a larger share of under 20 year olds among reported VOC than non-VOC cases

Lineage-specific growth of SARS-CoV-2 B.1.1.7 during the English national lockdown

https://virological.org/t/lineage-specific-growth-of-sars-cov-2-b-1-1-7-during-the-english-national-lockdown/575

B.1.1.7 proliferated in England, 87% (213/244) of lower tier local authorities

Average R value of 1.25

At the same time other lineages, R = 0.85 in most regions

Leading to 83% (203/244) of regions showing B.1.1.7 proliferation while other lineages diminished

United States

CDC trends (Saturday, 28th December)

https://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases

Official US hospitalizations

https://gis.cdc.gov/grasp/COVIDNet/COVID19_3.html

Cases, + 225,671 = 19,493,586

Up 6.9% over past 7 days

Hospitalizations, 125,220 (23,069) (7,930)

Deaths, 333,524
 
https://covidtracking.com

Vaccinations 2.1 million

Oxford/AstraZeneca Covid-19 vaccine, US

https://edition.cnn.com/world/live-news/coronavirus-pandemic-vaccine-updates-12-30-20/h_b62213a48c6b56472475c3ae654bce4d

Dr. Moncef Slaoui, chief scientific adviser for Operation Warp Speed

May be authorized for emergency use in the US in April

Several tens of millions should be manufactured in the US by then

VOC spread?

Colorado

B.1.1.7, is (VOC), 202012/01 

Variant has 17 mutations, eight alter the spike protein

First known cases in the United States

Two National Guard members

In isolation in Elbert County

No travel history, (Gov. Jared Polis)

Indicating likely community spread

Contact tracing interviews ongoing

National Guard, deployed Dec. 23 to the Good Samaritan Society assisted-living facility

All 26 residents tested positive for the familiar strain of the virus, four died

The Centers for Disease Control and Prevention

could lead to more cases and place greater demand on already strained health care resources

Southern California

https://www.washingtonpost.com/health/covid-variant-colorado-second-case/2020/12/30/1605b40a-4abc-11eb-a9f4-0e668b9772ba_story.html

San Diego County, 30-year-old man, tested Wednesday

No known travel history

Gov. Gavin Newsom

this new strain that we’ve identified obviously from the United Kingdom … 

Centers for Disease Control and Prevention

November, will eventually be able to analyse as many as 3,500 virus genomes per week

Francis Collins, Director of the National Institutes of Health

If there was a reason to work really hard on stopping community transmission, we have an even better reason now, because we’re up against a more formidable enemy

Things are getting bad enough already, just from the previous viral strain

Iran

Has launched human trials of its first domestic vaccine candidate

65,000 volunteers

Time scale, 45 to 60 days

N = 56

Buying vaccines from the World Health Organization-led Covax alliance

Planning to import a Chinese vaccine.

Download my two educational text books for free using this link: http://159.69.48.3

Hard copy of the Physiology Notes text book on ebay, https://www.ebay.co.uk/itm/-/15402036...

John’s research on text book efficacy, https://journals.sagepub.com/doi/full/10.1177/2158244015612517

## Morning Interview, Excellent vaccine news
 - [https://www.youtube.com/watch?v=Q3jjT1vdPsQ](https://www.youtube.com/watch?v=Q3jjT1vdPsQ)
 - RSS feed: https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg
 - date published: 2020-12-30 00:00:00+00:00

Seriously good news

## Oxford Vaccine Approved
 - [https://www.youtube.com/watch?v=8Pj4_aK-j8I](https://www.youtube.com/watch?v=8Pj4_aK-j8I)
 - RSS feed: https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg
 - date published: 2020-12-30 00:00:00+00:00

In the next few months, 
UK
Cases, + 53,135
Deaths, + 414

ChAdOx1

Three weeks for good level of immunity

After this people were not hospitalised

One dose can prevent serious disease

Day 22 to 3 months = 70% to 80%

Three billion doses of the vaccine

30 supply agreements and partner networks

Medicines and Healthcare products Regulatory Agency (MHRA)

Has approved two full doses of the Oxford-AstraZeneca vaccine

Not enough clear data to approve the half-dose, full-dose idea

First doses, Monday, 4th January

Pfizer

21 days is not the minimum gap, get more people protected quicker

Doctors can decide to give to pregnant and breast feeding women

People with allergies can also be considered

Joint Committee on Vaccination and Immunisation

Give as many people as possible their first dose of vaccine
 
Give as many vulnerable people some protection from Covid-19

Second dose, 4 to 12 weeks

Second dose, longer term protection.

Oxford already working on flexibility


Oxford/AstraZeneca Vaccine

MHRA, Medicines and Healthcare Products Regulatory Agency

Fast-track rolling review of the vaccine since November

Enters stage 4 on approval

Pre-orders

EU, 400 million doses

UK, 100 million

US, 300 million

China, 200 million

Japan, 120 million

Brazil, 100 million

Mexico, 77 million

Chile, 14,4 million

Indonesia, 100 million

Australia, 33.6 million

Egypt 30 million

Argentina 32 million

Ecuador 5 million

Canada 20 million

Argentina and Mexico to produce for Latin America

Vaccines alliance for poorer countries, 300 million

COVAX, 170 million

Three billion doses in 2021

Cost

£2

Transport / storage

Fridge temperatures

Lasts six months when refrigerated at 38–46°F (2–8°C)


Efficacy

Pascal Soriot, winning formula

62%    70% 90% 100% 

Strong response in older adults

Manufacturing

Keele, UK

Belgium

India, Serum Institute, 1 billion doses

Melbourne, Australia

Thailand, South East Asia

Netherlands and Germany

Across Europe

Shenzhen, China

US

Albuquerque, New Mexico

Maryland

Russia

Mexico


UK, 100 million

Four million ready to go

Fifteen million ready to put into vials

Mass rollout starts 4th January

One million people per week

Mass rollout

Important that no screening is required

Reactogenicity does not appear to be affected by the presences of antibodies to coronavirus.

US

Mr. Biden, 100 million shots in first 100 days

Published evidence base

AZ press release

https://www.astrazeneca.com/media-centre/press-releases/2020/azd1222hlr.html

Oxford vaccine, home site

https://www.ovg.ox.ac.uk

The Oxford Coronavirus Site

https://www.research.ox.ac.uk/Area/coronavirus-research/vaccine

The Jenner Institute

https://www.jenner.ac.uk

## Vaccination, excellent news
 - [https://www.youtube.com/watch?v=l3B7PyXblXY](https://www.youtube.com/watch?v=l3B7PyXblXY)
 - RSS feed: https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg
 - date published: 2020-12-30 00:00:00+00:00

Mass rollout in the UK from Monday, 4th January

